FIELD: medicine.
SUBSTANCE: in the tumour biopsy the presence of EBV, HHV-6, HHV-8 viruses is determined. If at least one of these viruses is identified, general and local antiviral therapy is used as an addition to the combined anti-tumour therapy.
EFFECT: invention application provides the ability to select the appropriate orbit NHL treatment strategy with an additional anti-viral effect.
5 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ASSESSING SEVERITY OF RETINOBLASTOMA IN CHILDREN | 2015 |
|
RU2578952C1 |
METHOD FOR DETERMINATION OF PRESCRIPTIONS TO CONDUCT COUNTER-HERPETIC THERAPY IN CASE OF CHRONIC CENTRAL BACTERIAL CORNEAL ULCERS | 2016 |
|
RU2623069C1 |
METHOD OF TREATING RECURRENT HERPETIC KERATITIS | 2023 |
|
RU2808915C1 |
METHOD OF ASSESSING SUITABILITY OF NATIVE DONOR CORNEA FOR KERATOTRANSPLANTATION | 2012 |
|
RU2481581C1 |
METHOD OF DIAGNOSTICS OF MIXED CHRONIC RECURRENT EYE INFECTIONS BY PCR METHOD | 2017 |
|
RU2658206C1 |
METHOD OF TREATING INFLAMMATORY OR DYSTROPHIC EYE DISEASES | 2019 |
|
RU2714193C1 |
METHOD OF EVALUATING STATE OF OPTIC NERVE IN OPTIC NEUROPATHY OF VARIOUS GENESES | 2015 |
|
RU2585429C1 |
METHOD OF TREATING VISUAL ORGAN LYMPHOMAS | 2013 |
|
RU2514638C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF LATENT AND ACTIVE FORMS OF HHV-6 INFECTION IN CHILDREN | 2023 |
|
RU2817089C1 |
METHOD FOR TREATING AND PREVENTING MALIGNANT LYMPHOMA OF CONJUNCTIVA USING BETA-APPLICATION THERAPY | 2000 |
|
RU2164161C1 |
Authors
Dates
2017-03-01—Published
2015-12-03—Filed